Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06232447 · ClinicalTrials.gov registry record · NA
Menthol, Inflammation, and Nicotine Transition Study
A NA study of Cigarette Smoking and Inflammatory Response, sponsored by Rosalind Franklin University of Medicine and Science.
- Recruiting
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT06232447: Recruiting NA study of Cigarette Smoking and Inflammatory Response, sponsored by Rosalind Franklin University of Medicine and Science.
NCT06232447 is a NA study of Cigarette Smoking and Inflammatory Response that is actively recruiting participants, run by Rosalind Franklin University of Medicine and Science. The registered enrollment target is 68 participants, below the 175-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06232447, a NA study of Cigarette Smoking and Inflammatory Response, is actively recruiting participants, sponsored by Rosalind Franklin University of Medicine and Science.
- RECRUITING
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will focus on examining the potential impact of menthol flavoring in cigarettes on biomarkers of systemic inflammation as a subclinical indicator of cardiovascular disease risk.
Primary Outcome
from serum in mg/dL
Conditions Studied
Interventions
- OTHER Cigarette Type Switching
Study Locations (1)
Illinois
- Rosalind Franklin University of Medicine and Science - North Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2024-03-26 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06232447 shows while recruiting
NCT06232447 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 175-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (61% lower).
The record links to 2 conditions, with Cigarette Smoking appearing as the primary indexed condition, and to 1 intervention - of which Cigarette Type Switching is the first listed.
NCT06232447 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06232447 about?
NCT06232447 is a clinical study titled "Menthol, Inflammation, and Nicotine Transition Study". This study will focus on examining the potential impact of menthol flavoring in cigarettes on biomarkers of systemic inflammation as a subclinical indicator of cardiovascular disease risk.
What is the current status of trial NCT06232447?
This trial is currently recruiting. It is a NA study. The enrollment target is 68 participants. The study started on 2024-03-26. Estimated completion is 2026-06.
What conditions does trial NCT06232447 study?
This clinical trial studies the following conditions: Cigarette Smoking, Inflammatory Response.
What interventions are being tested in trial NCT06232447?
The interventions under investigation include: Cigarette Type Switching (OTHER).
Who is sponsoring clinical trial NCT06232447?
This trial is sponsored by Rosalind Franklin University of Medicine and Science, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06232447 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06232447's enrollment target sits among peer trials
68 28th of 45 higher than 18 of 45 other Cigarette Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cigarette Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
-
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
RECRUITING · NA
-
Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI